1. Shield Supports active surveillance as the preferred administration tactic for men with minimal-hazard prostate cancer.seven Fashionable active surveillance protocols vary a little through the Lively monitoring tactic used in Shield. Some developments in active surveillance that have arisen Because the trial era include more regime use of magnetic resonance https://www.directivepublications.org/annals-of-urology/